Episode 286: The Status of NGS in Cancer With Ezra Cohen

Chadi sits down with Ezra Cohen, MD, Chief Medical Officer of Oncology at Tempus AI, for an in-depth discussion on the evolving role of next-generation sequencing (NGS) across the cancer continuum. Together, they explore how tissue-based testing, liquid biopsy, and measurable residual disease (MRD) assessments are reshaping precision oncology, why NGS remains underutilized in many patients, and the educational efforts needed to ensure genomic testing is ordered and applied appropriately to improve outcomes. Dr. Cohen also examines the growing role of artificial intelligence in interpreting and integrating genomic data, including Tempus' embedded AI tools designed to support both clinicians and patients.

Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. https://www.chadinabhan.com/

Watch all Healthcare Unfiltered episodes on YouTube. https://www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA